Insights on the Digital Pathology Market – Business Analysis, Market Key Restraints, Key Drivers, Growth Analysis And Segmental insights By 2029 | Leica Biosystems, Koninklijke Philips N.V., Hoffmann-La Roche Ltd

Digital Pathology Market

The global digital pathology market was valued at USD 541.61 million in 2019 and is expected to grow at 13.18% CAGR during the forecast study period.

Digital pathology integrates the collection, management, sharing, and analysis of pathology knowledge, including slides and data, in a digital world. Glass slides are created to have a high-resolution digital image that can be displayed on a computer screen or mobile device when glass slides are collected with a scanning tool. The rapid development of whole slide imaging (WSI) technology, coupled with innovations in software applications, LIS / LIMS interfacing, and high-speed networking, has enabled the complete integration of digital pathology into pathology workflows.

Digital pathology helps pathologists to easily and remotely communicate, analyze, and collaborate, with clarity and accuracy, thus increasing performance and productivity. Eventually, the future of digital pathology will include improved translational testing, computer-aided diagnosis (CAD), and personalized medicine. Over the years, digital pathology has created a new forum for clinical pathology, enabling convenient and accurate data sharing for diagnostic and multi-research pathology studies between scientists and laboratory technicians. Digital pathology is a promising sector within In-Vitro Diagnostics (IVD). Its case use extends to hospitals, research labs, pathologists, teaching and research institutes and pharmaceutical companies.

The analysis of the Digital Pathology Market by lays out the market size information and knowledge about the market trends along side factors and parameters influencing it in both short- and long-term. The research provides a comprehensive 360° view and insights, outlining the main outcomes of the industry. These essential insights assist the decision-makers in formulating better business plans and make informed decisions for improved profitability. Moreover, the analysis helps venture capitalists in understanding the businesses with a far better perspective and make aware decisions.

Obtain Brochure For Latest Technology Advancements @ 
https://straitsresearch.com/report/digital-pathology-market/request-sample

Impact of COVID-19 - 
Digital pathology is more important than ever amid the coronavirus pandemic. The most successful way to reduce the possibility of transmission is by encouraging pathologists to practice social distancing by encouraging remote research. Pathologists can work from home and monitor their microscopes remotely, display slides in real-time and from uploaded collections, exchange information with colleagues, and continue to provide remote diagnostics.

In April 2020, the FDA issued an immediate in effect guidance, ‘Enforcement Policy for Remote Digital Pathology Devices’ during ‘COVID-19 Public Health Emergency’, to extend the availability of devices for remote reviewing and reporting of scanned digital images of pathology slides.

By Type
Human Pathology
Veterinary Pathology

By Application
Drug Discovery
Disease Diagnosis
Teleconsultation
Training and Education

By End-User
Pharmaceutical and Biotechnology Companies
Hospitals and Reference Laboratories
Academic and Research Institutes

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth rate of Steerable Medical Devices in these regions, from 2019 to 2029, covering:
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

View this report with a detailed description and TOC @ https://straitsresearch.com/report/digital-pathology-market/toc

Key Digital Pathology Market Trends:
- The report identifies, determines, and forecasts the Global Digital Pathology Market segments based on their type, sub-type, technology used, applications, end-users, and regions.
- Industry to Industry Holds Largest Share in the Digital Pathology Market
- It examines the micro-markets based on their growth trends, development patterns, future prospects, and contribution to the overall market.
- Demand from Regional / geographical is Expected to Drive the Growth
- Rising Adoption of Market Segments in this Growth
- North American, Europe is Expected to Witness Higher Growth Rate over the Forecast Period
- It studies the competitive developments such as partnerships and collaborations, mergers and acquisitions (M&A), research and development (R&D) activities, product developments, and expansions in the Global Digital Pathology Market.

Key Questions Answered in The Report:
What will the Digital Pathology market growth rate?
What are the key factors driving the global Digital Pathology market?
Who are the key manufacturers in the Digital Pathology market space?
What are the market opportunities, market risk, and market overview of the Digital Pathology market?
What are sales, revenue, and price analysis of top manufacturers of the Digital Pathology market?
Who are the distributors, traders, and dealers of the Digital Pathology market?
What are the market opportunities and threats faced by the vendors in the global Steerable Medical Devices Industry?
What are sales, revenue, and price analysis by types and applications of the Digital Pathology Industry?
What are sales, revenue, and price analysis by regions of Digital Pathology industry?
What are the driving factors contributing to market growth during the short, medium, and long term?

Key Highlights -
The global digital pathology market was valued at USD 541.61 million in 2019 and is expected to grow at 13.18% CAGR during the forecast period.

The software segment is projected to see lucrative growth in the near future as the product helps to diagnose and synchronize patient data faster, where healthcare professionals can access this information remotely.

The availability of coherent workflow systems in pathology is expected to increase the use of computer-aided imaging technology in clinical research.

In August 2019, Leica Biosystems (US) launched the Aperio GT 450
In January 2019, Roche launched uPath enterprise software with improved speed, performance, and usability for digital pathology.

In June 2018, Royal Philips, a Dutch company, acquired the Irish PathXL, one of the largest image-based pathology analytics firms. This acquisition was conducted to develop advanced tools targeting computational biology, workflow solutions, education, and image analytics applications.

Some of the key players profiled in the global digital pathology market are Leica Biosystems, Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd, 3DHISTECH, Apollo Enterprise Imaging, XIFIN, Huron Digital Pathology, Visiopharm A/S., Corista, Indica Labs, Objective Pathology Services, Sectra AB, OptraSCAN, Glencoe Software, Inspirata, Inc., Mikroscan Technologies, Proscia Inc. and Kanteron Systems.

Browse Full Report @ 
https://straitsresearch.com/report/digital-pathology-market

Even if your business is a multinational venture or a single storefront, we believe innovation is the key to progress, in both what you build and how you promote your products and brands.

Buy Full Report with Detail Analysis with COVID-19 Impact – https://straitsresearch.com/buy-now/digital-pathology-market/global/

So let's put our minds together. We'll make your vision a reality and help you grow.

For more details, please contact us -
Straits Research
Email: sales@straitsresearch.com
Address: 825 3rd Avenue, New York, NY 10022
Tel: +1 646 480 7505, +44 208 068 9665
Website: https://straitsresearch.com/

About Us:
Regardless of whether you're looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with what customers purchase. We overcome the issues of our customers by recognizing and deciphering just the target group, while simultaneously generating leads with the highest precision. We seek to collaborate with our customers to deliver a broad spectrum of results through a blend of market and business research approaches. This approach of using various research and analysis strategies enables us to determine greater insights by eliminating the research costs.

This release was published on openPR.